Intracavernous injection as an option for aging men with erectile dysfunction

Area of Science:

• Gerontology
• Urology
• Sexual Medicine

Background:

• Sexuality is a key component of quality of life, even during aging.
• Erectile dysfunction (ED) treatment has advanced significantly due to research in impotence and erection pathophysiology.
• Intracavernous injection therapy was a primary treatment for ED before the advent of oral medications.

Purpose of the Study:

• To review the efficacy and safety of intracavernous injection therapy for erectile dysfunction in aging men.
• To compare intracavernous injection therapy with newer oral therapies for ED.
• To determine the continued relevance of intracavernous injection therapy in the current ED treatment landscape.

Main Methods:

• Review of existing literature on erectile dysfunction treatments.
• Analysis of efficacy and safety data for oral therapies.
• Analysis of efficacy and safety data for intracavernous injection therapy.

Main Results:

• Oral therapies offer a simpler treatment option for erectile dysfunction.
• Intracavernous injection therapy remains a viable and effective option for certain patients.
• Both treatment modalities have established safety profiles, with specific considerations for each.

Conclusions:

• Intracavernous injection therapy continues to be a valuable tool for managing erectile dysfunction in aging men.
• The choice between oral therapy and intracavernous injection depends on individual patient factors and treatment goals.
• Further research may refine the comparative effectiveness and patient selection for these ED treatments.